Index
- 20 Mcg Versus over 20 Mcg Estrogen Combined Oral Contraceptives for Contraception
- Abciximab in Primary Coronary Stenting of ST-Elevation Myocardial Infarction
- ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria
- ACE Inhibitors and Angiotensin Receptor Blockers for Progression of Non-Diabetic Renal Disease
- ACE Inhibitors and other Antihypertensive Drugs in Patients with Type 2 Diabetes
- ACE Inhibitors and Sudden Cardiac Death in Patients Following Acute Myocardial Infarction
- ACE Inhibitors for Secondary Prevention after Myocardial Infarction in Patients with Left Ventricular Dysfunction
- Acute Coronary Syndrome and Myocardial Infarction
- Acute Coronary Syndrome and Myocardial Infarction - Related Resources
- Administration…
- Air Travel and Illness
- Alcohol or Drug Intoxication - Quick Reference
- Aldosterone Receptor Antagonists Spironolactone and Eplerenone for Congestive Heart Failure
- Alpha-2 Adrenergic Agonists for the Prevention of Cardiac Complications Among Patients Undergoing Cardiac Surgery
- Alpha-2 Adrenergic Agonists for the Prevention of Cardiac Complications Among Patients Undergoing Non-Cardiac Surgery
- Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function
- Angiotensin-Receptor Blockers (Arb)and the Risk of Myocardial Infarction
- Angiotensin Receptor Blockers for Heart Failure
- Angiotensin Receptor Blockers or Angiotensin Converting Enzyme Inhibitors in the Prevention of Atrial Fibrillation
- Anticoagulants for Preventing Recurrence after Acute Ischaemic Stroke
- Antidepressants for Depression in Physical Illness
- Anti-Fibrinolytic Use for Minimising Blood Transfusion during Major Surgery
- Antihypertensive Agents for Preventing Diabetic Kidney Disease
- Antihypertensive Drugs and Incident Diabetes
- Antiplatelet Therapy for Patients with Non-Valvular Atrial Fibrillation
- Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
- Antipsychotics for Acute and Chronic Pain
- Antithrombotic Agents in Primary Health Care - Related Resources
- Antithrombotic Treatment after Stroke Due to Intracerebral Haemorrhage
- Aspirin in Unstable Angina
- Association of Glycaemic Control and Complications of Type 2 Diabetes
- Association of Systolic Blood Pressure and Complications of Type 2 Diabetes
- Atenolol for Preventing Stroke Recurrence
- Bed Rest for Myocardial Infarction
- Beta-Blockers, Calcium Antagonists, or Nitrates for Stable Angina
- Beta-Blockers after Acute Myocardial Infarction
- Beta-Blockers Against other Antihypertensive Drugs
- Beta Blockers for Unstable Angina
- Betablockers in Patients Without Heart Failure after Myocardial Infarction
- Blood Pressure Targets for People with Hypertension and Cardiovascular Disease
- Cabg Versus Ptca in Multi-Vessel Coronary Disease
- Calcium Channel Blockers Versus other Classes of Drugs for Hypertension
- Cardiology…
- Cardiovascular diseases…
- Cardiovascular Risk Associated with Cox-2 Inhibitors
- Carotid Artery Stenting Vs Endarterectomy for Carotid Artery Stenosis
- Celecoxib for Rheumatoid Arthritis
- Characteristics of Exertion-Related Acute Myocardial Infarction (MI)
- Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
- Clinical Examination in the Diagnosis of Heart Failure
- Clinical Examination in the Diagnosis of Peripheral Artery Disease of the Lower Extremity
- Clinical pharmacology…
- Clopidogrel and Aspirin in Acute ST-Segment Elevation Myocardial Infarction (STEMI)
- Clopidogrel Plus Aspirin Versus Aspirin Alone for Preventing Cardiovascular Disease in Acute Non-ST Segment Coronary Syndromes
- Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Events
- Cochrane review…
- Combined Aspirin-Oral Anticoagulant Therapy Compared with Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
- Complete Versus Culprit-Only Revascularization in ST-Elevation Myocardial Infarction
- Coronary Artery Bypass Grafting (Cabg) Versus Medical Treatment
- Coronary Heart Disease - Related Resources
- Cpap and Bipap Non-Invasive Ventilation in Patients with Acute Cardiogenic Pulmonary Oedema
- Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation
- Desmopressin for Minimising Perioperative Allogeneic Blood Transfusion
- Diagnostic and Prognostic Value of Ambulatory Electrocardiographic Monitoring in Older Patients
- Diagnostic Classification of Acute Coronary Syndromes
- Direct Oral Anticoagulants Versus Warfarin Among Atrial Fibrillation Patients with Chronic Kidney Disease
- Dronedarone in Atrial Fibrillation
- Drug Treatment for Hypertension - Related Resources
- Early Treatment with ACE Inhibitors in Acute Myocardial Infarction
- Early Treatment with Beta-Blockers in Acute Myocardial Infarction
- Early Treatment with Calcium Channel Blockers in Acute Cardiovascular Event
- Early Treatment with Nitrates in Acute Myocardial Infarction
- Early Versus Later Commencement of Feeding after Colorectal Surgery
- Education, Counselling and Supervised Exercise for Improving Prognosis of Coronary Artery Disease
- Effect of Pexelizumab on Mortality in Patients with Acute Myocardial Infarction or Undergoing Coronary Artery Bypass Surgery
- Efficacy and Safety of Cholesterol Lowering by Statins
- Emergency medicine…
- Enhanced Glucose Control for Preventing and Treating Diabetic Neuropathy in Type 1 Diabetes
- Erythropoietin for Chronic Renal Failure Anaemia
- Estrogen Plus Progestin for Primary Prevention in Healthy Postmenopausal Women
- Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
- Evidence summary…
- Exercise-Based Cardiac Rehabilitation in Heart Transplant Recipients
- Exercise-Based Rehabilitation for Coronary Heart Disease
- Ezetimibe for the Prevention of Cardiovascular Disease
- Facilitated Percutaneous Coronary Intervention (Pci) Vs Pci Alone
- Febuxostat for Hyperuricaemia in Chronic Gout
- Female…
- Fibrates for Primary Prevention of Cardiovascular Disease
- First-Line Renin Angiotensin System Inhibitors Versus other Drug Classes for Hypertension
- Fondaparinux for Acute Coronary Syndromes
- Garlic and Cardiovascular Risk Factors
- Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes
- Glycaemic Control for Slowing the Progression of Microvascular Complications in Diabetes Mellitus
- Graduated Compression Stockings in the Prevention of Postoperative Venous Thromboembolism
- Gynaecology…
- Heparin for the Prevention of Venous Thromboembolism in General Medical Patients (Excluding Stroke and Myocardial Infarction)
- Home-Based Versus Centre-Based Cardiac Rehabilitation
- Home Blood Pressure (Bp) Measurement Compared to Office Bp
- Homocysteine Lowering Interventions for Preventing Cardiovascular Events
- Hormonal Contraception in Overweight or Obese Women
- Hormonal Contraception - Related Resources
- Hormone Replacement Therapy and the Risk of Stroke
- Hormone Therapy for Preventing Cardiovascular Disease in Post-Menopausal Women
- Hydroxyurea in the Treatment of High-Risk Essential Thrombocythaemia
- Hypertension: Diagnosis, Initial Investigations and Starting Treatment - Related Resources
- Implantable Cardiac Defibrillators
- Implantable Cardioverter-Defibrillator (ICD) - Related Resources
- Indications for Fibrinolytic Therapy in Suspected Myocardial Infarction
- Influenza Vaccines for Preventing Cardiovascular Disease
- Insulin Added on Metformin in Type 2 Diabetes
- Intensive Glucose Lowering in Type 2 Diabetes
- Intensive Insulin Therapy and Early Macrovascular Disease in Young Individuals with Type 1 Diabetes
- Intensive Versus Moderate Statin Therapy
- Internal medicine…
- Interventions in the Management of Serum Lipids for Preventing Stroke Recurrence
- Intravenous Magnesium for Acute Myocardial Infarction
- Ischaemic Stroke and Myocardial Infarction Risk with Combined Oral Contraceptives
- Lifestyle Changes in Women with Polycystic Ovary Syndrome
- Lipid-Lowering Pharmacotherapy for Lower Limb Ischaemia
- List of Abbreviations
- Local Versus General Anaesthesia for Carotid Endarterectomy
- Losartan Versus Atenolol for Diabetic Hypertensive Patients with LVH
- Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
- Low-Molecular Weight Heparin in Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy
- Low-Molecular-Weight-Heparins Compared to Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Treated with Thrombolysis
- Low Molecular Weight Heparins for Acute Coronary Syndromes
- Male Hypogonadism and Hormone Replacement - Related Resources
- Mediterranean-Style Diet for the Primary and Secondary Prevention of Cardiovascular Disease
- Music for Coronary Heart Disease Patients
- Neurology…
- Nitrates for Acute Heart Failure Syndromes
- Nitrates in Acute Myocardial Infarction
- Nitrates in Myocardial Infarction
- Nitrates in Unstable Angina
- Noac Versus Warfarin Postpci in Atrial Fibrillation
- Nsaids and Risk of Acute Myocardial Infarction
- Obesity and Waist-to-Hip-Ratio and Risk of Myocardial Infarction
- Obstetrics…
- Off-Pump or Minimally Invasive Coronary Artery Bypass Compared with Percutaneous Coronary Intervention
- Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
- Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
- Oral Antidiabetic Drugs and GLP-1 Analogues in the Treatment of Type 2 Diabetes - Related Resources
- Oxygen Therapy for Acute Myocardial Infarction
- Patient Education in the Management of Coronary Heart Disease
- Pcsk9 Inhibitors for Prevention of Cardiovascular Disease
- Percutaneous Coronary Intervention after Fibrinolysis
- Perioperative Betablockers for Preventing Surgeryrelated Mortality and Morbidity in Adults Undergoing Cardiac Surgery
- Perioperative Beta-Blockers in Non-Cardiac Surgery
- Perioperative Statin Therapy during and after Noncardiac Vascular Surgery
- Peroxisome Proliferator-Activated Receptor Gamma Agonists for Preventing Recurrent Stroke and other Vascular Events in Patients with Stroke or Transient Ischaemic Attack
- Pharmacological Interventions for Hypertensive Emergencies
- Pharmacology…
- Phosphate Binders in Chronic Kidney Disease
- Physiotherapy…
- Plasma Homocysteine Level as a Risk Factor for Major Coronary Events
- Platelet Glycoprotein Iib/Iiia Receptor Antagonists in Cardiovascular Disease
- Positive Pressure Airway Support for Cardiogenic Pulmonary Oedema
- Prehospital 12-Lead Electrocardiography with Advanced Notification of Emergency Department in Acute Myocardial Infarction
- Preoperative Assessment - Related Resources
- Preoperative Statin Therapy
- Prevention of Bone Disease in Kidney Transplant Recipients
- Prevention of Myocardial Infarction and Death by Antidyslipidemic Therapy
- Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
- Primary Angioplasty Versus Intravenous Thrombolysis for Acute Myocardial Infarction
- Primary Stenting Versus Primary Balloon Angioplasty for Treating Acute Myocardial Infarction
- Prognostic Role of Troponin T Versus Troponin I in Unstable Angina Pectoris
- Promoting Patient Utilisation of Cardiac Rehabilitation
- Prothrombin Complex Concentrate for Reversal of Vitamin K Antagonist Treatment
- Psychological and Pharmacological Interventions for Depression in Patients with Coronary Artery Disease
- Psychological Interventions for Coronary Heart Disease
- Psychosocial Interventions for Smoking Cessation in Patients with Coronary Heart Disease
- Reduced Saturated Fat for Preventing Cardiovascular Disease
- Reduction of Cardiovascular Risk after Stopping Smoking
- Reteplase for Thrombolysis in Acute Myocardial Infarction
- Risk of a Venous Thromboembolism during the Postpartum Period
- Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
- Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
- Rosiglitazone for Type 2 Diabetes Mellitus
- Routine or Selective Invasive Strategy for Acute Coronary Syndrome
- Selective and Traditional Non-Steroidal Anti-Inflammatory Drugs and the Risk of Atherothrombosis
- Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease
- Sglt-2 Inhibitors in Type 2 Diabetes
- Smoking Cessation as Treatment for Intermittent Claudication
- Smoking Cessation for the Secondary Prevention of Coronary Heart Disease
- Sotalol after Myocardial Infarction
- Spironolactone for Hypertension
- Statins for Acute Coronary Syndrome
- Statins for Dialysis Patients
- Statins for Improving Renal Outcomes
- Statins for Kidney Transplant Recipients
- Statins for Secondary Prevention in Elderly Patients
- Statins for the Primary Prevention of Cardiovascular Disease
- Stem Cell Therapy for Chronic Ischaemic Heart Disease and Congestive Heart Failure
- Stem Cell Treatment for Acute Myocardial Infarction
- Stroke Risk in Patients with Atrial Fibrillation and Heart Failure
- Sulphonylurea for Type 2 Diabetes
- Surgery for Morbid Obesity
- Surgery…
- Systematic review…
- Systemic Safety of Bevacizumab Versus Ranibizumab for Neovascular Age-Related Macular Degeneration
- Tavi Versus Open Surgery for Valve Replacement in Aortic Stenosis
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- The Effect of Coronary Artery Bypass Graft Surgery (Cabg) on Survival
- The Effect of Statins on Mortality and the Incidence of Coronary Events in Secondary Prevention of Ischaemic Heart Disease
- The Effect on ACE Inhibitors on Mortality and Morbidity in Patients with Heart Failure
- The Use of Diltiazem, Verapamil and Short-Acting Nifedipine in Heart Failure
- Thienopyridine Derivatives (Ticlopidine, Clopidogrel) Versus Aspirin or Aspirin-Dipyridamole for Preventing Serious Vascular Events in High Risk Patients
- Thoracic surgery…
- Timing of Thrombolytic Therapy in Acute Myocardial Infarction
- Topical Application of Tranexamic Acid for the Reduction of Bleeding
- Transdermal and Oral Hormone Replacement Therapy and the Risk of Stroke
- Transfusion Thresholds for Guiding Allogeneic Red Blood Cell Transfusion
- Treatment of Hypertension in Peripheral Arterial Disease
- Treatment of Obesity - Related Resources
- Vaccinations - Related Resources
- Varenicline for Smoking Cessation
- Verapamil in Patients with Cardiovascular Disease
- Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
- Warfarin for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Cerebral Ischaemia